ReviewWorld journal of clinical cases2022

Semaglutide might be a key for breaking the vicious cycle of metabolically associated fatty liver disease spectrum?

Maja Cigrovski Berkovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.